Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
2.
Metab Syndr Relat Disord ; 12(1): 49-55, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24206171

RESUMO

BACKGROUND: The question of whether the metabolic syndrome truly reflects a single disease entity with a common underlying pathology remains unclear. In this study, we assess whether metabolic syndrome represents an underlying disease construct in a large population-based sample of Andean Hispanic adults and examine its relationship to subclinical atherosclerosis. METHODS: The study sample was comprised of 2513 participants. Confirmatory factor analysis (CFA) was used to identify a metabolic syndrome latent factor using waist circumference, systolic and diastolic blood pressure, high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), and glucose levels as indicators. The relationship with subclinical atherosclerosis, measured by carotid intima media thickness (cIMT), was assessed using structural equation modeling. RESULTS: Results supported the proposed structure of the metabolic syndrome latent factor evidenced by adequate fit indexes. HDL-C did not significantly load on the metabolic syndrome latent factor (standardized factor loading=0.01, P=0.88). The metabolic syndrome latent factor was significantly associated with cIMT in women (B=0.007, P<0.001) and men (B=0.008, P<0.001) after controlling for age, low-density lipoprotein cholesterol and smoking. CONCLUSIONS: Our findings suggest that metabolic syndrome components, such as waist circumference, blood pressure, TGs, and glucose levels, but not HDL-C, share a common underlying pathophysiology that may contribute to the progression of atherosclerosis in Andean Hispanics. Its longitudinal association with cardiovascular disease should be the focus of future research.


Assuntos
Aterosclerose/complicações , Síndrome Metabólica/complicações , Adulto , Aterosclerose/diagnóstico , Aterosclerose/etnologia , Glicemia/análise , Pressão Sanguínea , Espessura Intima-Media Carotídea , HDL-Colesterol/metabolismo , Diástole , Progressão da Doença , Análise Fatorial , Feminino , Humanos , Masculino , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/etnologia , Pessoa de Meia-Idade , Peru/etnologia , Análise de Regressão , Sístole , Triglicerídeos/metabolismo , Circunferência da Cintura
3.
Int J Cardiol ; 105(2): 198-202, 2005 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-16243113

RESUMO

Latin America is undergoing the epidemiologic transition that occurred earlier in developed countries, and is likely to face a gigantic epidemic of heart disease in the next few years unless urgent action is taken. The first essential component of any effective cardiovascular disease (CVD) control program is to establish reliable estimates of cardiovascular disease-related morbidity and mortality. However, such data from population-based studies in Latin America are still lacking. In this paper, we present the design and operation of PREVENCION (Estudio Peruano de Prevalencia de Enfermedades Cardiovasculares, for Peruvian Study of the Prevalence of Cardiovascular diseases). PREVENCION is an ongoing population-based study on a representative sample of the civilian non-institutionalized population of the second largest city in Peru. Its population is comparable to the rest of the Peruvian urban population and closely resembles other Latin American populations in countries such as Bolivia and Ecuador. Our study will contribute to the enormous task of understanding and preventing CVD in Latin America.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Ensaios Clínicos como Assunto/métodos , Vigilância da População , Doenças Cardiovasculares/epidemiologia , Humanos , Incidência , Peru/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA